Calcium plus vitamin D supplementation and fat mass loss in female very low-calcium consumers: potential link with a calcium-specific appetite control

Br J Nutr. 2009 Mar;101(5):659-63. doi: 10.1017/s0007114508030808.

Abstract

This randomized, double-blind, placebo-controlled study was conducted to compare the effect of a 15-week weight-reducing programme ( -2900 kJ/d) coupled with a calcium plus vitamin D (calcium+D) supplementation (600 mg elemental calcium and 5 microg vitamin D, consumed twice a day) or with a placebo, on body fat and on spontaneous energy/macronutrient intake. Sixty-three overweight or obese women (mean age 43 years, mean BMI 32 kg/m2) reporting a daily calcium intake < 800 mg participated in present study. Anthropometric variables, resting energy expenditure and spontaneous energy intake were measured before and after the 15-week programme. The calcium+D supplementation induced no statistically significant increase in fat mass loss in response to the programme. However, when analyses were limited to very low-calcium consumers only (initial calcium intake < or =600 mg/d, n 7 for calcium+D, n 6 for placebo), a significant decrease in body weight and fat mass (P < 0.01) and in spontaneous dietary lipid intake (P < 0.05) was observed in the calcium+D but not in the placebo group. In very low-calcium consumers, change in fat mass was positively correlated with change in lipid intake. During the weight-reducing programme, a calcium+D supplementation was necessary in female overweight/obese very low-calcium consumers to reach significant fat mass loss that seemed to be partly explained by a decrease in lipid intake. We propose that this change in lipid intake could be influenced by a calcium-specific appetite control.

Trial registration: ClinicalTrials.gov NCT00353054.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Anthropometry / methods
  • Appetite Regulation / drug effects
  • Body Constitution / drug effects
  • Calcium / therapeutic use*
  • Calcium, Dietary / administration & dosage
  • Combined Modality Therapy
  • Dietary Fats / administration & dosage
  • Dietary Supplements*
  • Double-Blind Method
  • Drug Combinations
  • Energy Intake / drug effects
  • Energy Metabolism / drug effects
  • Female
  • Humans
  • Obesity / drug therapy
  • Obesity / physiopathology
  • Obesity / therapy
  • Overweight / drug therapy*
  • Overweight / physiopathology
  • Overweight / therapy
  • Treatment Outcome
  • Vitamin D / therapeutic use*
  • Weight Loss / drug effects*

Substances

  • Calcium, Dietary
  • Dietary Fats
  • Drug Combinations
  • Vitamin D
  • Calcium

Associated data

  • ClinicalTrials.gov/NCT00353054